RSS   Newsletter   Contact   Advertise with us
Post Online Media

Eleven Biotherapeutics appoints Richard F. Fitzgerald as interim CFO

Eleven BiotherapeuticsOctober 16, 2017, Cambridge, Mass., USA - Eleven Biotherapeutics, a late-stage clinical oncology company, announced the appointment of Richard F. Fitzgerald as interim chief financial officer.
Mr. Fitzgerald brings over two decades of financial and strategic leadership to Eleven Biotherapeutics.

Most recently, he served as a consultant to private life science based companies from July 2017 through October 2017.

Before that, Mr. Fitzgerald served as Chief Financial officer of Pavmed Inc., where he completed its IPO in April 2016.

He previously served as Chief Financial Officer at Techprecision Corporation and Nucleonics Inc., and in several financial and business development positions of increasing responsibility at Exelon Corporation.

Mr. Fitzgerald holds his B.S. in Business Administration from Bucknell University.

 

 LATEST MOVES FROM Massachusetts 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.